Showing results (141-150 of 157) with videos related to

Sort By:
Pageof 16
JAMA Neurology|January 7, 2020
Tau Positron Emission Tomographic Findings in a Former US Football Player With Pathologically Confirmed Chronic Traumatic EncephalopathyWilliam G Mantyh, Salvatore Spina, Alex Lee, et al.
Toxics|February 28, 2023
Interlaboratory Study to Evaluate a Testing Protocol for the Safety of Food Packaging CoatingsMaricel Marin-Kuan, Vincent Pagnotti, Amaury Patin, et al.
Neurobiology of Aging|May 28, 2021
Multimodal neuroimaging of sex differences in cognitively impaired patients on the Alzheimer's continuum: greater tau-PET retention in femalesLauren Edwards, Renaud La Joie, Leonardo Iaccarino, et al.
Molecular Genetics and Metabolism Reports|September 30, 2014
The retarded hair growth (rhg) mutation in mice is an allele of ornithine aminotransferase (Oat)Jason J Bisaillon, Legairre A Radden, Eric T Szabo, et al.
JAMA Network Open|March 3, 2020
Effect of Pregnenolone vs Placebo on Self-reported Chronic Low Back Pain Among US Military Veterans: A Randomized Clinical TrialJennifer C Naylor, Jason D Kilts, Lawrence J Shampine, et al.
International Clinical Psychopharmacology|February 4, 2015
A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military Veterans resistant to antidepressant treatmentJennifer C Naylor, Jason D Kilts, Daniel W Bradford, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 5, 2021
Comparing ATN-T designation by tau PET visual reads, tau PET quantification, and CSF PTau181 across three cohortsKarine Provost, Leonardo Iaccarino, David N Soleimani-Meigooni, et al.
Clinical Pharmacology and Therapeutics|June 1, 2024
Discovery and Model-Informed Drug Development of a Controlled-Release Formulation of Nonracemic Amisulpride that Reduces Plasma Exposure but Achieves Pharmacodynamic Bioequivalence in the BrainSeth C Hopkins, Siriporn Toongsuwan, Taryn J Corriveau, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 29, 2020
Beyond the looking glass: recent advances in understanding the impact of environmental exposures on neuropsychiatric diseaseJonathan A Hollander, Deborah A Cory-Slechta, Felice N Jacka, et al.
Nature Medicine|April 2, 2020
A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating κ-opioid antagonism as a treatment for anhedoniaAndrew D Krystal, Diego A Pizzagalli, Moria Smoski, et al.
Pageof 16